Methylphenidate (Ritalin, Concerta) Ritalin Is… a central nervous system stimulant. Created in 1954, Ritalin has been in use for over sixty years. (Check out a History of Ritalin here). It was […]
New research helps explain how Ritalin sharpens attention
Date: April 29, 2022 Source: University of Pittsburgh Science Daily Summary: Researchers found animals that had taken methylphenidate performed better on a visual task of attention, and that the improvement […]
Exercise is the Most Important Medicine for COVID-19
Torres, Georgia PhD; Constantinou, Demitri MBChB, FACSM; Gradidge, Philippe PhD; Patel, Deepak MD; Patricios, Jon MBBCh, MMedSci Current Sports Medicine Reports 22(8):p 284-289, August 2023. | DOI: 10.1249/JSR.0000000000001092 Abstract COVID-19 infection and long COVID […]
Risk of smell loss from covid has plummeted since 2020
New research shows steep drops in the rates of smell loss with recent omicron variants By Aara’L Yarber August 2023 When the pandemic began, losing your sense of smell was considered […]
Can This Common Medication Help Reduce The Risk Of Long COVID?
A recent study suggests that the treatment may help some high-risk people following an infection. By Casey Clark Aug 29, 2023 It seems like every time you turn on the news […]
SARS-CoV-2 and the risk of Parkinson’s disease: facts and fantasy
Marcelo Merello, Kailash P Bhatia, Jose A Obeso Published: November 27, 2020 DOI: https://doi.org/10.1016/S1474-4422(20)30442-7 Lancet Neurology VOLUME 20, ISSUE 2, P94-95, FEBRUARY 2021 During the pandemic it has become clear that severe […]
Clinical characteristics and outcome of COVID-19 patients with Parkinson’s disease: a hospital-based case–control study in Shanghai, China
Front. Aging Neurosci., 05 May 2023 Sec. Parkinson’s Disease and Aging-related Movement DisordersVolume 15 – 2023 | https://doi.org/10.3389/fnagi.2023.1138418 Li Wu1† Jun Shen1† Yuhan Jiang1 Xiaolei Shen1 Ping Wang1 Xin Nie2 Wenyan Kang3,4* Jianren Liu1* Wei Chen1* Background: Clinical manifestations of […]
Early-stage trial for Parkinson’s disease therapy shows signs of promise
Small trial of Bemdaneprocel, which aims to replace dopamine-producing neurons, raises hope for treatment. Hannah Devlin Science correspondent 28 Aug 2023 03.00 EDT Scientists have reported early success in a trial […]
COVID-19 and neurological disorders: what might connect Parkinson’s disease to SARS-CoV-2 infection
Salvatore Iacono1† Giuseppe Schirò1† Chiara Davì1 Sergio Mastrilli2 Michelle Abbott3 Fabrizio Guajana1 Valentina Arnao4 Paolo Aridon1 Paolo Ragonese1 Cesare Gagliardo1 Claudia Colomba3 Nicola Scichilone5 Marco D’Amelio1* Front. Neurol., 18 May 2023 Sec. Movement Disorders Volume 14 – 2023 | https://doi.org/10.3389/fneur.2023.1172416 SARS-CoV-2 infection leading […]
Covid to blame for just 1% of weekly deaths from all causes across the US, CDC data shows
By ALEXA LARDIERI U.S. DEPUTY HEALTH EDITOR DAILYMAIL.COM 29 August 2023 Covid was to blame for just 1 percent of weekly deaths from all causes across the US in the most […]